Company Profile
Vivos Therapeutics Stock Price, News & Analysis
Company overview
Business overview
Vivos Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Vivos Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Vivos Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Vivos Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
VVOS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Vivos Therapeutics’s catalysts are sleep-apnea device adoption, reimbursement, and broader dental-sleep workflow penetration. The story improves as the installed base becomes more durable.
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.